{"id":"foradil-p-24-g","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Tachycardia"},{"rate":"2-5%","effect":"Palpitations"},{"rate":"2-5%","effect":"Headache"},{"rate":"1-2%","effect":"Dysphonia"},{"rate":"1-2%","effect":"Muscle cramps"}]},"_chembl":{"chemblId":"CHEMBL3646970","moleculeType":"Small molecule","molecularWeight":"577.66"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by stimulating the beta2-adrenergic receptors in the lungs, leading to bronchodilation and improved airflow. This results in improved lung function and symptoms in patients with asthma and COPD.","oneSentence":"Foradil P 24µg is a long-acting beta2-adrenergic receptor agonist (LABA) used to control and prevent bronchospasm in patients with asthma and COPD.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:32:41.757Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Asthma"},{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT01256086","phase":"PHASE2","title":"Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2010-12","conditions":"Asthma","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Foradil P 24µg","genericName":"Foradil P 24µg","companyName":"MEDA Pharma GmbH & Co. KG","companyId":"meda-pharma-gmbh-co-kg","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Foradil P 24µg is a long-acting beta2-adrenergic receptor agonist (LABA) used to control and prevent bronchospasm in patients with asthma and COPD. Used for Asthma, Chronic obstructive pulmonary disease (COPD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}